Genentech gets rights to AC Immune's Alzheimer's antibodies
Genentech has licensed exclusive worldwide rights to AC Immune's (developing therapeutics for CNS diseases and cancer) anti-beta-amyloid antibodies for Alzheimer's and other diseases.
- Large Molecule
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.